In defense of Canada’s drug plan managers von Hollis, Aidan, PhD

Volltext

Pull me - push you? The disparate financing mechanisms of drug research in global health von Matthey, Max Alexander, Hollis, Aidan

Volltext

The effect of antibiotic usage on resistance in humans and food-producing animals: a longitudinal, One Health analysis using European data von Rahman, Sakib, Hollis, Aidan

Volltext

Persistence of resistance: a panel data analysis of the effect of antibiotic usage on the prevalence of resistance von Rahman, Sakib, Kesselheim, Aaron S., Hollis, Aidan

Volltext

Estimating the clinical cost of drug development for orphan versus non-orphan drugs von Jayasundara, Kavisha, Hollis, Aidan, Krahn, Murray, Mamdani, Muhammad, Hoch, Jeffrey S, Grootendorst, Paul

Volltext

The private versus public contribution to the biomedical literature during the COVID-19, Ebola, H1N1, and Zika public health emergencies von Beall, Reed F, Moradpour, Javad, Hollis, Aidan

Volltext

Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus von Morel, Chantal M., Lindahl, Olof, Harbarth, Stephan, de Kraker, Marlieke E. A., Edwards, Suzanne, Hollis, Aidan

Volltext

Attitudes, behaviours and barriers to public health measures for COVID-19: a survey to inform public health messaging von Lang, Raynell, Benham, Jamie L, Atabati, Omid, Hollis, Aidan, Tombe, Trevor, Shaffer, Blake, Burns, Katharina Kovacs, MacKean, Gail, Léveillé, Tova, McCormack, Brandi, Sheikh, Hasan, Fullerton, Madison M, Tang, Theresa, Boucher, Jean-Christophe, Constantinescu, Cora, Mourali, Mehdi, Manns, Braden J, Marshall, Deborah A, Hu, Jia, Oxoby, Robert J

Volltext

Repurposing existing drugs for new uses: a cohort study of the frequency of FDA-granted new indication exclusivities since 1997 von Sahragardjoonegani, Babak, Beall, Reed F, Kesselheim, Aaron S, Hollis, Aidan

Volltext

Market concentration of new antibiotic sales von Rahman, Sakib, Lindahl, Olof, Morel, Chantal M., Hollis, Aidan

Volltext

The Health Impact Fund: incentives for improving access to medicines von Banerjee, Amitava, Dr, Hollis, Aidan, PhD, Pogge, Thomas, PhD

Volltext

The impact of pharmaceutical rebates on patients’ drug expenditures von Memedovich, K. Ally, BHSc, Beall, Reed, PhD, Clement, Fiona, PhD, Manns, Braden, MD MSc, Hollis, Aidan, PhD

Volltext

Applying a diffusion of innovations framework to characterise diffusion groups and more effectively reach late adopters: a cross-sectional study on COVID-19 vaccinations in Canada... von Memedovich, Ally, Steele, Brian, Orr, Taylor, Hollis, Aidan, Salmon, Charleen, Hu, Jia, Zinszer, Kate, Williamson, Tyler, Beall, Reed

Volltext

Sustainable Financing of Innovative Therapies: A Review of Approaches von Hollis, Aidan

Volltext

An Optional Delinked Reward System: Making Pharmaceutical Innovation Work for Everyone von Hollis, Aidan

Volltext

Orphan Drug Pricing and Costs: A Case Study of Kalydeco and Orkambi von Hollis, Aidan

Volltext

The Impact of Tiered-Pricing Framework on Generic Entry in Canada von Zhang, Wei, Sun, Huiying, Guh, Daphne P, Lynd, Larry D, Hollis, Aidan, Grootendorst, Paul, Anis, Aslam H

Volltext

Knowledge Gaps in the Understanding of Antimicrobial Resistance in Canada von McCubbin, Kayley D, Anholt, R Michele, de Jong, Ellen, Ida, Jennifer A, Nóbrega, Diego B, Kastelic, John P, Conly, John M, Götte, Matthias, McAllister, Tim A, Orsel, Karin, Lewis, Ian, Jackson, Leland, Plastow, Graham, Wieden, Hans-Joachim, McCoy, Kathy, Leslie, Myles, Robinson, Joan L, Hardcastle, Lorian, Hollis, Aidan, Ashbolt, Nicholas J, Checkley, Sylvia, Tyrrell, Gregory J, Buret, André G, Rennert-May, Elissa, Goddard, Ellen, Otto, Simon J G, Barkema, Herman W

Volltext

Patient income and health innovation von Moradpour, Javad, Hollis, Aidan

Volltext

The economic theory of cost‐effectiveness thresholds in health: Domestic and international implications von Moradpour, Javad, Hollis, Aidan

Volltext